Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JuanBiQiangGu + methotrexate is a combination therapy used primarily for treating rheumatoid arthritis. This combination consists of JuanBiQiangGu Granules (JBQG), a traditional Chinese medicine formula, administered alongside methotrexate, which is a conventional disease-modifying antirheumatic drug (DMARD). ## Composition and Classification The combination therapy pairs JuanBiQiangGu Granules, taken three times daily (8 mg tid), with weekly methotrexate (typically 7.5 mg qw)[2]. This represents a form of combination therapy where a traditional Chinese medicine is used alongside a conventional Western pharmaceutical. ## Therapeutic Use and Effectiveness Clinical research has demonstrated that JuanBiQiangGu Granules combined with methotrexate can effectively: - Alleviate joint inflammation in rheumatoid arthritis patients - Reduce the incidence of adverse reactions to methotrexate - Provide good safety profile for patients[1][2] A randomized controlled trial evaluated this combination against methotrexate monotherapy over a 12-week treatment period. The study measured various clinical indices including DAS28-ESR (Disease Activity Score), HAQ-DI (Health Assessment Questionnaire Disability Index), and Sharp scores, along with inflammatory markers such as CRP, ESR, TNF-α, IL-1β, IL-6, IL-17, and INF-γ[2]. ## Mechanism of Action While the specific mechanism of JuanBiQiangGu Granules is not fully detailed in the search results, methotrexate is known to be an immunosuppressant that serves as an anchor drug among disease-modifying antirheumatic agents[3]. The combination appears to work synergistically to control inflammation and reduce joint damage in rheumatoid arthritis. ## Development Status This combination has undergone clinical trials, including a randomized controlled trial registered with the identifier ChiCTR2100046373[2]. The research was conducted by institutions including Shanghai University of Traditional Chinese Medicine and Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine[2]. ## Safety Profile The combination therapy has demonstrated a favorable safety profile, with JuanBiQiangGu Granules specifically noted to reduce the incidence of adverse reactions associated with methotrexate[1][2]. This is significant as methotrexate can cause various side effects, including liver toxicity when combined with certain other medications[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on JuanBiQiangGu + methotrexate.